|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
7 months to Dec 31, 2021
|
|
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net (Loss) Income | ||||
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||||
| Interest earned | ||||
| Unrealised Gain/loss from marketable securities hold in the trust account | ||||
| Investment income | ||||
| Changes in operating assets and liabilities: | ||||
| Other receivables | ||||
| Prepaid expenses | ||||
| Accrued Offering Cost | ||||
| Prepaid income tax | ||||
| Accrued expenses | ||||
| Accrued offering costs | ||||
| Other payables | ||||
| Franchise tax payable | ||||
| Income tax payable | ||||
| Due to related party | ||||
| Net cash used in operating activities | ||||
| Cash flows from investing activities: | ||||
| Investment of Cash in Trust Account - redemption | ||||
| Investment of Cash in Trust Account - extension | ||||
| Withdrawal from Trust Account | ||||
| Withdrawal from Trust Account for tax payment | ||||
| Net cash provided by investing activities | ||||
| Cash flows from financing activities: | ||||
| Interest earned on Cash account | ||||
| Redemption of common stock | ||||
| Proceeds from sponsor working capital loan | ||||
| Proceeds from extension loan | ||||
| Net cash provided by (used in) financing activities | ||||
| Net change in cash | ||||
| Cash at the beginning of the period | ||||
| Cash at the end of the period | ||||
| Supplemental disclosure of non-cash financing activities: | ||||
| Deferred underwriting fee payable | ||||
| Value of Class A common stock subject to redemption | ||||
| Redemption payable | ||||
| Re-measurement of common stock subject to possible redemption | ||||
Loading...